Structure Therapeutics Inc.
GPCRPharmaceutical Preparations · SIC 2834 · CIK 0001888886
Revenue FY2025
—
Net Income
$(0.14B)
EPS (Basic)
$-0.80
Net Margin
—
ROE
-9.3%
Total Equity
$1.52B
Shares Out
214M
Structure Therapeutics Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2022–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 6 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Platinum Investment Management
Platinum Investment Management
$4.8M
1.2%
+35.1%
OrbiMed Advisors
OrbiMed Advisors
$118.6M
0.6%
+49.7%
Deerfield Management Company
Deerfield Management Company
$58.3M
0.3%
+41.4%
Baker Bros. Advisors
Baker Bros. Advisors
$76.9M
0.3%
—
Alps Advisors
Alps Advisors
$3.9M
0.0%
+24.6%
Adage Capital Management
Adage Capital Management
$4.0M
0.0%
NEW
Insider Transactions
Reading stored insider transactions…